InsiderTrades.com logo
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
From Autonomix   |   Ad
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Invest in Autonomix today.

MGCI Insider Trading

Insider Ownership Percentage: 1.30%
Insider Buying (Last 12 Months): £20,142.19
Insider Selling (Last 12 Months): GBX 0

M&G Credit Income Investment Insider Trading History Chart

This chart shows the insider buying and selling history at M&G Credit Income Investment by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

M&G Credit Income Investment Share Price & Price History

Current Price: GBX 93
Price Change: +0.30 (1.20%)
As of 11/29/2023 01:00 AM ET

This chart shows the closing price history over time for MGCI up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
From Autonomix   |   Ad
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Invest in Autonomix today.

M&G Credit Income Investment Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/5/2023Barbara PowleyInsiderBuy22,237GBX 89£19,790.93
9/12/2023Barbara PowleyInsiderBuy386GBX 91£351.26
10/20/2022Richard Bole´atInsiderBuy10,000GBX 88£8,800
1/20/2022Jane RoutledgeInsiderBuy19,696GBX 99£19,499.04
1/29/2021Richard Bole´atInsiderBuy10,000GBX 88£8,800
See Full Table
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
From Autonomix   |   Ad
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Invest in Autonomix today.

SEC Filings (Institutional Ownership Changes) for M&G Credit Income Investment (LON:MGCI)

65.46% of M&G Credit Income Investment stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

M&G Credit Income Investment Trust plc invests in a portfolio of public and private debt and debt-like instruments. The company was incorporated in 2018 and is based in London, the United Kingdom.
Read More on M&G Credit Income Investment

Today's Range

Now: GBX 93
Low: 90.42
High: 93

50 Day Range

MA: GBX 90.58
Low: 87
High: 93

52 Week Range

Now: GBX 93
Low: 83.40
High: 98.60

Volume

117,059 shs

Average Volume

131,876 shs

Market Capitalization

£131.88 million

P/E Ratio

1,860.00

Dividend Yield

8.13%

Beta

0.43

Who are the company insiders with the largest holdings of M&G Credit Income Investment?

M&G Credit Income Investment's top insider shareholders include:
  1. Barbara Powley (Insider)
  2. Jane Routledge (Insider)
  3. Richard Bole´at (Insider)
Learn More about top insider investors at M&G Credit Income Investment.
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
From Autonomix   |   Ad
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Invest in Autonomix today.